Skip to main content

Wound Heal

3
Pipeline Programs
15
Companies
15
Clinical Trials
5 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
2
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket

Drug Modality Breakdown

Peptide
2100%
+ 16 programs with unclassified modality

Competitive Landscape

15 companies ranked by most advanced pipeline stage

Ilya Pharma
Ilya PharmaSweden - Uppsala
1 program
1
ILP100-TopicalPhase 21 trial
Active Trials
NCT05608187Terminated1Est. Dec 2024
Biocorp
BiocorpFrance - Issoire
1 program
1
FSR Peptide 20μMPhase 1Peptide1 trial
Active Trials
NCT04473859Completed49Est. Apr 2009
Xequel Bio
Xequel BioSC - Mount Pleasant
1 program
1
FSR Peptide 20μMPhase 1Peptide
ConvaTec
ConvaTecNJ - Bridgewater
4 programs
EDX110N/A1 trial
InnovaMatrix® ACN/A1 trial
InnovaMatrix® ACN/A1 trial
innovaMatrix ACN/A1 trial
Active Trials
NCT07209358Recruiting298Est. Dec 2026
NCT06606210Recruiting120Est. Apr 2026
NCT06616844Recruiting194Est. Jul 2026
+1 more trials
Coloplast
ColoplastAustralia - Mulgrave
1 program
Biatain AgN/A1 trial
Active Trials
NCT05923749Completed180Est. Jan 2025
Emanate Biomedical
Emanate BiomedicalNY - New York
1 program
Emanate TrayN/A1 trial
Active Trials
NCT05282615Completed45Est. Jan 2023
Tempo Therapeutics
Tempo TherapeuticsCA - San Diego
1 program
MAP Wound MatrixN/A1 trial
Active Trials
NCT06600152Active Not Recruiting40Est. Aug 2026
Noxsano
NoxsanoOH - Cincinnati
1 program
Noxsano BandageN/A1 trial
Active Trials
NCT04123093Terminated13Est. Sep 2020
Colorado Therapeutics
Colorado TherapeuticsCO - Louisville
1 program
PowerHeal™ Bioelectric BandageN/A1 trial
Active Trials
NCT07329114Recruiting150Est. Aug 2027
Acera Surgical
Acera SurgicalMO - St. Louis
1 program
RestrataN/A1 trial
Active Trials
NCT04829331Terminated5Est. Jan 2022
Enterprise Therapeutics
1 program
SynEx Wound CleanserN/A
Synedgen
SynedgenCA - Claremont
1 program
SynEx Wound CleanserN/A1 trial
Active Trials
NCT05743283Recruiting100Est. Sep 2025
BirchBioMed
BirchBioMedON - Toronto
1 program
Vehicle Cream Base Emulsion Moisturizer + PetrolatumN/A1 trial
Active Trials
NCT04169438Completed10Est. Sep 2020
Imbed Biosciences
Imbed BiosciencesWI - Middleton
1 program
Wound HealingN/A
Mission Therapeutics
Mission TherapeuticsUK - Cambridge
1 program
Wound HealingN/A1 trial
Active Trials
NCT03204851Unknown100Est. Dec 2020

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
Ilya PharmaILP100-Topical
BiocorpFSR Peptide 20μM
Colorado TherapeuticsPowerHeal™ Bioelectric Bandage
ConvaTecEDX110
ConvaTecInnovaMatrix® AC
ConvaTecInnovaMatrix® AC
Tempo TherapeuticsMAP Wound Matrix
ConvaTecinnovaMatrix AC
ColoplastBiatain Ag
SynedgenSynEx Wound Cleanser
Emanate BiomedicalEmanate Tray
Acera SurgicalRestrata
BirchBioMedVehicle Cream Base Emulsion Moisturizer + Petrolatum
NoxsanoNoxsano Bandage
Mission TherapeuticsWound Healing

Clinical Trials (15)

Total enrollment: 1,372 patients across 15 trials

Evaluating Safety and Biological Effect on Wound Healing of ILP100-Topical in Subjects With Diabetic Foot Ulcers

Start: Sep 2022Est. completion: Dec 20241 patients
Phase 2Terminated
NCT04473859BiocorpFSR Peptide 20μM

Study to Evaluate the Safety of FSR Peptide Versus Placebo Following Punch Biopsy

Start: Mar 2008Est. completion: Apr 200949 patients
Phase 1Completed
NCT07329114Colorado TherapeuticsPowerHeal™ Bioelectric Bandage

Healing Electroceutical Dressing for the Recovery of Open Wounds (HERO)

Start: Feb 2026Est. completion: Aug 2027150 patients
N/ARecruiting

EDX110 Randomized Control Trial for Treatment of DFUs

Start: Oct 2025Est. completion: Dec 2026298 patients
N/ARecruiting
NCT06616844ConvaTecInnovaMatrix® AC

IDEAL: Efficacy of Porcine Placental Extracellular Matrix Augmented Plus Standard of Care (SOC) Versus SOC Alone for the Management of Diabetic Foot Ulcers

Start: Feb 2025Est. completion: Jul 2026194 patients
N/ARecruiting
NCT06606210ConvaTecInnovaMatrix® AC

INNOVEN: Efficacy of Porcine Placental Extracellular Matrix Plus Standard of Care (SOC) Versus SOC Alone

Start: Sep 2024Est. completion: Apr 2026120 patients
N/ARecruiting

Safety of Microporous Annealed Particle (MAP) Wound Matrix in Patients With Clean Surgical Wounds.

Start: Aug 2024Est. completion: Aug 202640 patients
N/AActive Not Recruiting
NCT07170566ConvaTecinnovaMatrix AC

A Retrospective, Observational Study of the Real-world Safety and Performance of InnovaMatrix® AC at a Single Centre

Start: May 2024Est. completion: Aug 202567 patients
N/ACompleted

A RCT Evaluating the Clinical Benefit of a Silver Dressing in the Treatment of Venous Leg Ulcers

Start: Jun 2023Est. completion: Jan 2025180 patients
N/ACompleted
NCT05743283SynedgenSynEx Wound Cleanser

Efficacy of SynEx Wound Rinse in Civilian Surrogates of Combat Injury Wounds

Start: Apr 2023Est. completion: Sep 2025100 patients
N/ARecruiting

Impact of Daily Use of The Emanate Tray Adjunct to Full Mouth Debridement Compared to Full Mouth Debridement Alone

Start: Feb 2022Est. completion: Jan 202345 patients
N/ACompleted

Utility of Restrata With Split Thickness Skin Graft to Reconstruct the Forearm Donor Site

Start: Apr 2021Est. completion: Jan 20225 patients
N/ATerminated
NCT04169438BirchBioMedVehicle Cream Base Emulsion Moisturizer + Petrolatum

Pilot Study Investigating a Restorative Wound Care Cream Together With Petrolatum on Surgical Excisions

Start: Nov 2019Est. completion: Sep 202010 patients
N/ACompleted
NCT04123093NoxsanoNoxsano Bandage

Safety and Efficacy of the Noxsano Wound Care Bandage

Start: Aug 2019Est. completion: Sep 202013 patients
N/ATerminated

Microlyte Dressing in the Management of Wounds

Start: Oct 2016Est. completion: Dec 2020100 patients
N/AUnknown

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

5 actively recruiting trials targeting 1,372 patients
15 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.